BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.367,43 PKT +6,08 PKT +0,45 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
12.04.11 Sika buy Vontobel Research
11.04.11 Novartis buy Vontobel Research
11.04.11 Sonova hold Vontobel Research
08.04.11 Nestlé halten Independent Research GmbH
08.04.11 Lindt buy Société Générale Group S.A. (SG)
07.04.11 Novartis buy Vontobel Research
06.04.11 Sonova hold Vontobel Research
04.04.11 Zurich Insurance halten Independent Research GmbH
04.04.11 Swiss Life buy Vontobel Research
04.04.11 Swisscom hold UniCredit Research
01.04.11 Novartis buy Vontobel Research
01.04.11 Logitech buy Vontobel Research
01.04.11 Zurich Insurance buy Nomura
31.03.11 Sonova hold Vontobel Research
31.03.11 Zurich Insurance buy Vontobel Research
31.03.11 Adecco SA buy Vontobel Research
30.03.11 Sonova hold Vontobel Research
30.03.11 Novartis buy Nomura
30.03.11 ABB (Asea Brown Boveri) sell UniCredit Research
30.03.11 Schindler hold Vontobel Research
29.03.11 Geberit halten Öko Invest
29.03.11 Novartis kaufen Hamburger Sparkasse AG (Haspa)
29.03.11 Novartis buy Société Générale Group S.A. (SG)
29.03.11 Lonza hold Vontobel Research
29.03.11 Sonova kaufen Die Actien-Börse
28.03.11 Novartis kaufen Independent Research GmbH
25.03.11 Sonova hold Vontobel Research
24.03.11 UBS overweight Morgan Stanley
23.03.11 Novartis buy Vontobel Research
22.03.11 ABB (Asea Brown Boveri) kaufen Hamburger Sparkasse AG (Haspa)
22.03.11 Straumann hold Vontobel Research
22.03.11 Sonova equal-weight Morgan Stanley
22.03.11 Kühne + Nagel International hold Vontobel Research
22.03.11 Zurich Insurance buy Société Générale Group S.A. (SG)
25.03.11 Nestlé neutral J.P. Morgan Cazenove
21.03.11 Sika buy Vontobel Research
17.03.11 Sonova hold Vontobel Research
17.03.11 Lindt buy Société Générale Group S.A. (SG)
16.03.11 Novartis buy UBS AG
16.03.11 Kühne + Nagel International equal-weight Morgan Stanley